Evidence map›Paper›PMID 40721793›Full record

ArticleBMC biology2025

Integration of pre-trained protein language models with equivariant graph neural networks for peptide toxicity prediction.

Shihu Jiao, Xiucai Ye, Tetsuya Sakurai, Quan Zou, Wu Han, Chao Zhan

Abstract read
In one paragraph

Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. IntelligentFrontiers in cellular and infection microbiology · 2026
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shihu JiaoYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, China.
Xiucai YeDepartment of Computer Science, University of Tsukuba, Tsukuba, 3058577, Japan. yexiucai@cs.tsukuba.ac.jp.
Tetsuya SakuraiDepartment of Computer Science, University of Tsukuba, Tsukuba, 3058577, Japan.
Quan ZouYangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, China.
Wu HanDepartment of Statistics, Stanford University, 100 Infinity Way, Mountain View, CA, 94043, USA. kevinwh@stanford.edu.
Chao ZhanHarbin Medical University Cancer Hospital, Harbin, 150001, China. zhanchaoHMU@proton.me.

Funding

JSPS KAKENHI Grant JP22K12144JSPS KAKENHI Grant JP23H03411JST Grant JPMJPF2017National Natural Science Foundation of China 62301368National Natural Science Foundation of China 62450002
6 · The paper itself

Abstract

backgroundPeptide-based therapeutics have great potential due to their versatility, high specificity, and suitability for a variety of therapeutic applications. Despite these advantages, the inherent toxicities of some peptides pose challenges in drug development. Several computational methods have been developed to allow rapid and efficient large-scale screening of peptide toxicity. However, these methods mainly rely on the primary sequence and often ignore critical structural information, which limits their predictive accuracy.

resultsIn this study, we introduce a novel framework named StrucToxNet that integrates a pre-trained protein language model with an equivariant graph neural network to improve peptide toxicity prediction. By combining sequence embeddings from the ProtT5 language model and 3D structural data predicted by ESMFold, StrucToxNet can capture both sequential and spatial characteristics of peptides. Testing on the independent dataset indicates that StrucToxNet outperforms existing sequence-based models in various metrics, achieving higher balanced accuracy and overall performance.

conclusionsThe results demonstrate the robustness and generalizability of StrucToxNet, marking it a reliable tool in the computational screening of toxic peptides and facilitating safer peptide-based drug development.

Indexed as

Neural Networks, ComputerPeptidesGraph Neural NetworksPeptidesEquivariant graph neural networksPeptidesProtein language modelStructureToxicity

Identifiers

PMID40721793
PMCPMC12306123

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.